Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,401–3,425 of 7,816 matching trials · page 137 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Validation Of The Flemish Montreal Cognitive Assessment (MoCA) For Persons With Hearing Impairment NCT06400173 Cognitive screening; Audiological Assessment Runs in: Belgium · 1 site |
NA other |
UNKNOWN | 450 | University Ghent OTHER |
2024-05-06 |
|
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease NCT02137460 Runs in: South Korea · 1 site |
NA other |
COMPLETED | 721 | Seoul National University Hospital OTHER |
2024-05-03 |
|
Turkish Speech Analysis Development Study NCT05732519 Runs in: Turkey (Türkiye) · 1 site |
NA other |
UNKNOWN | 180 | mihrimah ozturk OTHER |
2024-05-03 |
|
First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) NCT05921929 Fluoroethylnormemantine (FENM) Runs in: Belgium · 1 site |
PHASE1 symptomatic-cholinergic |
WITHDRAWN | 0 | ReST Therapeutics INDUSTRY |
2024-05-03 |
|
A Study to Evaluate XTR006 in Chinese Volunteers NCT06151795 XTR006 Runs in: China · 1 site |
PHASE1 other |
COMPLETED | 10 | Sinotau Pharmaceutical Group INDUSTRY |
2024-05-03 |
|
Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects NCT06151808 XTR006 Runs in: China · 1 site |
NA other |
COMPLETED | 42 | Sinotau Pharmaceutical Group INDUSTRY |
2024-05-03 |
|
Treatment of Psychosis and Agitation in Alzheimer's Disease NCT02129348 Lithium; Placebo Runs in: United States · 4 sites |
PHASE2 other |
COMPLETED | 77 | New York State Psychiatric Institute OTHER |
2024-05-02 |
|
To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease NCT06393413 Jiedu Yizhi Formula; Donepezil Hydrochloride Tablets Runs in: China · 1 site |
EARLY_PHASE1 symptomatic-cholinergic |
COMPLETED | 62 | Changchun University of Chinese Medicine OTHER |
2024-05-02 |
|
Eye Scanning for Safety Driving NCT06396273 Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 30 | Loughborough University OTHER |
2024-05-02 |
|
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand NCT03958630 11C-ER176; 11C-PIB; Positron Emission Tomography (PET) Scan Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 13 | National Institute of Mental Health (NIMH) NIH |
2024-05-01 |
|
Music Therapy as a Treatment for Delirium in Acutely Hospitalized Older Patients NCT05398211 Preferred Recorded Music (PRM); Preferred Live Music (PLM) Runs in: Norway · 1 site |
NA other |
COMPLETED | 26 | Oslo University Hospital OTHER |
2024-04-30 |
|
Huntington's Disease Young Adult Study 2.0 NCT06391619 No intervention Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 154 | University College, London OTHER |
2024-04-30 |
|
A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017 NCT06388551 LY03017; LY03017-Placebo Runs in: China · 1 site |
PHASE1 other |
UNKNOWN | 60 | Luye Pharma Group Ltd. INDUSTRY |
2024-04-29 |
|
Dual-task Exercise in People With Cognitive Impairment NCT06389812 Dual-task exercise traning Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 30 | Loughborough University OTHER |
2024-04-29 |
|
Spatial Navigation for the Early Detection of Alzheimer's Disease. NCT06385951 Procedure for patients; Procedure for healthy controls Runs in: Belgium · 1 site |
NA other |
RECRUITING | 160 | University Hospital, Ghent OTHER |
2024-04-26 |
|
Systemic and Central Inflammation in AD NCT06384378 11C-ER176 Runs in: United States · 1 site |
PHASE2 other |
UNKNOWN | 40 | The Methodist Hospital Research Institute OTHER |
2024-04-25 |
|
An Investigation of Levetiracetam in Alzheimer's Disease NCT03489044 Levetiracetam; Placebo Oral Tablet Runs in: United Kingdom · 1 site |
PHASE2 other |
COMPLETED | 8 | University of Oxford OTHER |
2024-04-24 |
|
Feasibility of an Online, Self-administered Cognitive Screening Tool in Older Patients Undergoing Ambulatory Surgery NCT05094817 Brain Health Assessment; Demographics questionnaire; PHQ-2; AFT; GA... Runs in: Canada · 1 site |
NA other |
COMPLETED | 78 | Women's College Hospital OTHER |
2024-04-24 |
|
The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease NCT06380725 Transcranial alternating current stimulation(real stimulation); Tra... |
NA other |
UNKNOWN | 60 | Anhui Provincial Hospital OTHER_GOV |
2024-04-24 |
|
Virtual Reality Cognitive Training for Mild Cognitive Impairment NCT06380894 Virtual Reality Cognitive Training; Active Control Runs in: Singapore · 1 site |
NA other |
COMPLETED | 20 | Changi General Hospital OTHER |
2024-04-24 |
|
Home-based tDCS for Apathy in Alzheimer's Disease NCT04855643 home-based active tDCS; home-based sham tDCS Runs in: United States · 1 site |
NA other |
TERMINATED | 3 | The University of Texas Health Science Center, Houston OTHER |
2024-04-23 |
|
UK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI) NCT06379594 Runs in: United Kingdom · 1 site |
NA other |
ENROLLING_BY_INVITATION | 200 | South London and Maudsley NHS Foundation Trust OTHER |
2024-04-23 |
|
BEAM: Brain-Eye Amyloid Memory Study NCT02524405 Pittsburgh Compound B [11C]-PIB Runs in: Canada · 5 sites |
NA other |
UNKNOWN | 345 | Sunnybrook Health Sciences Centre OTHER |
2024-04-22 |
|
Viamigo for People With Dementia and Their Informal Caregivers NCT05648864 Viamigo Runs in: Netherlands · 1 site |
NA other |
UNKNOWN | 48 | Maastricht University Medical Center OTHER |
2024-04-22 |
|
Investigating Neurocognitive Disorders Epidemiology NCT06375213 Plasma tau phosphorylated at Thr217; Neurocognitive examination Runs in: Thailand · 1 site |
NA other |
RECRUITING | 990 | King Chulalongkorn Memorial Hospital OTHER |
2024-04-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial